Photo: A Juul vaping system with accessory pods in varying flavors. Bill O'Leary/The Washington Post via Getty Images

E-cigarette company Juul is facing mounting backlash from users who claim the nicotine salts in Juul products have made them more addictive, Wired reports.

Why it matters: As a result, the company is facing several lawsuits, two filed in April and one in June, which assert that Juul was being deceptive in marketing itself as a better alternative to cigarettes.

What they're saying:

  • All three filings — in a U.S. District Court in Northern California, the San Francisco Superior Court, and a U.S. District Court in New York — claim Juul's products made customers more addicted to nicotine.
  • One user claimed Juul did not help them quit smoking but, “the intense dosage of nicotine salts delivered by the Juul products resulted in an increased nicotine addiction, and an increased consumption of nicotine by Colgate.”
  • Another user, who is 15 years old, said he has become “heavily addicted to nicotine,” making him “anxious, highly irritable and prone to angry outbursts,” and perform poorly in school.

The other side: Victoria Davis, a spokesperson for Juul, tells Axios that "JUUL Labs does not believe the cases have merit and will be defending them vigorously." 

Timing: Juul had until June 19 to turn in any paperwork to the Food and Drug Administration relating to Juul’s marketing campaigns, product design, and consumer complaints on the product as it relates to youth use.

  • These documents will be key in examining whether Juul is deceiving the public by marketing itself as a “cigarette alternative” for adult smokers, as well as whether its contributing to a tobacco problem for younger generations, per a previous Axios report.

Go deeper:

Go deeper

Updated 25 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 9 p.m. ET: 13,273,537 — Total deaths: 577,006 — Total recoveries — 7,367,106Map.
  2. U.S.: Total confirmed cases as of 9 p.m. ET: 3,424,304 — Total deaths: 136,432 — Total recoveries: 1,049,098 — Total tested: 41,764,557Map.
  3. Politics: Biden welcomes Trump wearing mask in public but warns "it’s not enough"
  4. Public health: Four former CDC heads say Trump's undermining of agency puts lives at risk — CDC director: U.S. could get coronavirus "under control" in 4–8 weeks if all wear masks.

Bank CEOs brace for worsening economic scenario

JPMorgan CEO Jamie Dimon. Photo: J. Lawler Duggan/For The Washington Post via Getty Images

Wells Fargo swung to its first loss since the financial crisis — while JPMorgan Chase and Citigroup reported significantly lower profits from a year earlier — as the banks set aside billions of dollars more in the second quarter for loans that may go bad.

Why it matters: The cumulative $28 billion in loan loss provisions that banks have so far announced they’re reserving serves as a signal they’re preparing for a colossal wave of loan defaults as the economy slogs through a coronavirus-driven downturn.

4 hours ago - Health

Moderna's vaccine spurred immune system response to coronavirus

Moderna's stock rose 16% after hours on this news. Photo: Jakub Porzycki/NurPhoto via Getty Images

Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus, and there were "no trial-limiting safety concerns," according to a new study published in the New England Journal of Medicine.

Why it matters: The phase one trial is still small and does not definitively determine how effective the vaccine is. But Anthony Fauci of the National Institutes of Health, which is running the trial, told the Wall Street Journal that these data make it "pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."